New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
14:09 EDTSNTA, DBA, RFMD, OIS, PERI, HRBHigh option volume stocks; OIS DBA HRB RFMD SNTA PERI
News For OIS;DBA;HRB;RFMD;SNTA;PERI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
07:04 EDTSNTASynta Pharmaceuticals presents preclinical results from Hsp90 platform
Synta Pharmaceuticals announced that a poster highlighting preclinical results from its Hsp90 inhibitor Drug Conjugate platform is being presented at the 26th EORTC-NCI-AACR Symposium in Barcelona. “This poster highlights our ongoing evaluation of multiple candidates from the HDC platform. The preclinical results for our lead candidates not only demonstrate broad activity across several tumor types, but also the ability for HDCs to induce prolonged antitumor effects as compared to well-established cytotoxic agents,” said Weiwen Ying, Vice President, Discovery Chemistry at Synta. “In addition, the platform is not limited to using traditional cytotoxic therapeutics as payloads. A number of commonly used small molecule anticancer agents may also be incorporated, including tyrosine kinase inhibitors, proteosome inhibitors, small molecule immunotherapeutics, and other molecularly targeted agents. By leveraging the preferential retention characteristic of the Hsp90 targeting arm of an HDC in tumors, intratumoral exposure and antitumor potency for a wide array of payloads can be potentially improved." "We are encouraged by the progress the team has achieved to date with candidates arising from the HDC platform and the promise that the platform holds for both internal development and partnerships,” said Anne Whitaker, President and CEO of Synta. “We continue to evaluate options for efficiently advancing candidates from this platform and look forward to providing updates in the future.”
November 18, 2014
06:14 EDTOISOil States initiated with a Neutral at SunTrust
Target $63.
November 17, 2014
09:16 EDTRFMDRF Micro Devices and TriQuint recommended at Craig-Hallum
Craig-Hallum recommends RF Micro Devices (RFMD) and TriQuint (TQNT) and believes the combined company will imply EPS in the $1.40 range. The analyst said the RF Semi space has some of the best growth in tech and reiterates its Buy ratings for both companies.
08:48 EDTRFMDSkyworks, Avago, and RF Micro Devices recommended at BofA/Merrill
Subscribe for More Information
November 14, 2014
08:48 EDTRFMDRF Micro should be bought on any merger related weakness, says Pacific Crest
Subscribe for More Information
November 13, 2014
09:33 EDTHRBH&R Block downgraded to Neutral from Buy at Northcoast
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use